311 related articles for article (PubMed ID: 25818449)
1. Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing.
Hoffman MD; Benoit DS
Biomaterials; 2015 Jun; 52():426-40. PubMed ID: 25818449
[TBL] [Abstract][Full Text] [Related]
2. Emerging ideas: Engineering the periosteum: revitalizing allografts by mimicking autograft healing.
Hoffman MD; Benoit DS
Clin Orthop Relat Res; 2013 Mar; 471(3):721-6. PubMed ID: 23179118
[TBL] [Abstract][Full Text] [Related]
3. The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.
Hoffman MD; Xie C; Zhang X; Benoit DS
Biomaterials; 2013 Nov; 34(35):8887-98. PubMed ID: 23958029
[TBL] [Abstract][Full Text] [Related]
4. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering.
Zhang X; Xie C; Lin AS; Ito H; Awad H; Lieberman JR; Rubery PT; Schwarz EM; O'Keefe RJ; Guldberg RE
J Bone Miner Res; 2005 Dec; 20(12):2124-37. PubMed ID: 16294266
[TBL] [Abstract][Full Text] [Related]
5. Combined delivery of FGF-2, TGF-β1, and adipose-derived stem cells from an engineered periosteum to a critical-sized mouse femur defect.
Romero R; Travers JK; Asbury E; Pennybaker A; Chubb L; Rose R; Ehrhart NP; Kipper MJ
J Biomed Mater Res A; 2017 Mar; 105(3):900-911. PubMed ID: 27874253
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase (MMP)-degradable tissue engineered periosteum coordinates allograft healing via early stage recruitment and support of host neurovasculature.
Li Y; Hoffman MD; Benoit DSW
Biomaterials; 2021 Jan; 268():120535. PubMed ID: 33271450
[TBL] [Abstract][Full Text] [Related]
7. The effect of mesenchymal stem cell sheets on structural allograft healing of critical sized femoral defects in mice.
Long T; Zhu Z; Awad HA; Schwarz EM; Hilton MJ; Dong Y
Biomaterials; 2014 Mar; 35(9):2752-9. PubMed ID: 24393269
[TBL] [Abstract][Full Text] [Related]
8. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering.
Xie C; Reynolds D; Awad H; Rubery PT; Pelled G; Gazit D; Guldberg RE; Schwarz EM; O'Keefe RJ; Zhang X
Tissue Eng; 2007 Mar; 13(3):435-45. PubMed ID: 17518596
[TBL] [Abstract][Full Text] [Related]
9. Dual Role of Mesenchymal Stem Cells Allows for Microvascularized Bone Tissue-Like Environments in PEG Hydrogels.
Blache U; Metzger S; Vallmajo-Martin Q; Martin I; Djonov V; Ehrbar M
Adv Healthc Mater; 2016 Feb; 5(4):489-98. PubMed ID: 26693678
[TBL] [Abstract][Full Text] [Related]
10. Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts.
Hoffman MD; Van Hove AH; Benoit DS
Acta Biomater; 2014 Aug; 10(8):3431-41. PubMed ID: 24751534
[TBL] [Abstract][Full Text] [Related]
11. Autologous mesenchymal stem cells loaded in Gelfoam(®) for structural bone allograft healing in rabbits.
Lee JY; Choi MH; Shin EY; Kang YK
Cell Tissue Bank; 2011 Nov; 12(4):299-309. PubMed ID: 20652421
[TBL] [Abstract][Full Text] [Related]
12. Development of a cell-free and growth factor-free hydrogel capable of inducing angiogenesis and innervation after subcutaneous implantation.
Dos Santos BP; Garbay B; Fenelon M; Rosselin M; Garanger E; Lecommandoux S; Oliveira H; Amédée J
Acta Biomater; 2019 Nov; 99():154-167. PubMed ID: 31425892
[TBL] [Abstract][Full Text] [Related]
13. [Reconstruction of segmental bone defect by gene modified tissue engineering bone combined with vascularized periosteum].
Li JJ; Zhao Q; Wang H; Yang J; Yuan Q; Cui SQ; Li L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Nov; 23(6):502-6. PubMed ID: 18269027
[TBL] [Abstract][Full Text] [Related]
14. Bone tissue engineering by way of allograft revitalization: mechanistic and mechanical investigations using a porcine model.
Runyan CM; Ali ST; Chen W; Calder BW; Rumburg AE; Billmire DA; Taylor JA
J Oral Maxillofac Surg; 2014 May; 72(5):1000.e1-11. PubMed ID: 24742484
[TBL] [Abstract][Full Text] [Related]
15. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells.
van Gastel N; Torrekens S; Roberts SJ; Moermans K; Schrooten J; Carmeliet P; Luttun A; Luyten FP; Carmeliet G
Stem Cells; 2012 Nov; 30(11):2460-71. PubMed ID: 22911908
[TBL] [Abstract][Full Text] [Related]
16. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.
Yazici C; Takahata M; Reynolds DG; Xie C; Samulski RJ; Samulski J; Beecham EJ; Gertzman AA; Spilker M; Zhang X; O'Keefe RJ; Awad HA; Schwarz EM
Mol Ther; 2011 Aug; 19(8):1416-25. PubMed ID: 21206485
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic Differentiation Evaluation of an Engineered Extracellular Matrix Based Tissue Sheet for Potential Periosteum Replacement.
Xing Q; Qian Z; Kannan B; Tahtinen M; Zhao F
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23239-47. PubMed ID: 26419888
[TBL] [Abstract][Full Text] [Related]
18. Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.
Collette NM; Yee CS; Hum NR; Murugesh DK; Christiansen BA; Xie L; Economides AN; Manilay JO; Robling AG; Loots GG
Bone; 2016 Jul; 88():20-30. PubMed ID: 27102547
[TBL] [Abstract][Full Text] [Related]
19. Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle.
Shekaran A; García JR; Clark AY; Kavanaugh TE; Lin AS; Guldberg RE; García AJ
Biomaterials; 2014 Jul; 35(21):5453-61. PubMed ID: 24726536
[TBL] [Abstract][Full Text] [Related]
20. Biofunctionalizing devitalized bone allografts through polymer-mediated short and long term growth factor delivery.
Sharmin F; Adams D; Pensak M; Dukas A; Lieberman J; Khan Y
J Biomed Mater Res A; 2015 Sep; 103(9):2847-54. PubMed ID: 25689463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
